About Daniel Rizzuto
Daniel Rizzuto is a founder, president and CTO, director at Nia Therapeutics.
Daniel Rizzuto first appears on SEC filings in 2018.
Experience
This experience comes from Daniel Rizzuto's profile and from SEC filings. For roles taken from filings, the years are when the filings name Daniel Rizzuto in the role, so the role may have started earlier or lasted longer.
Nia Therapeutics, Inc. Current
Founder, President and CTO, director
2018 – Present · Allston, MA
Develops a brain implant to treat memory loss in people with traumatic brain injuries.
UP
University of Pennsylvania
Director of Cognitive Neuromodulation
2014 – 2018
AS
Allen Institute for Brain Science
Sr. Scientific Program Manager
2013 – 2014
VS
Varian Medical Systems
Clinical and Pre-Market Regulatory Affairs Manager
2012 – 2013
SI
Swedish Neuroscience Institute
Research Manager
2009 – 2012
NN
Northstar Neuroscience
Research Project Manager
2007 – 2008
CT
California Institute of Technology
Research Project Manager
2005 – 2007
CA
Caltech
Postdoctoral Fellow
2002 – 2005
Key Colleagues at Startups
The people Daniel Rizzuto works with at each company, as listed on that company's latest Form D.
Nia Therapeutics, Inc. · Form D/A, Jun 3, 2026
Michael Kahana
Founder and CEO, director
JW
Jonathan Wachter
Director
Daniel Utin
Chief Software Architect
LG
Larry Greenberg
Director
Milton Morris
Independent Board Director